AAAAAA

   
Results: 1-25 | 26-50 | 51-53
Results: 1-25/53
LONG-TERM TRENDS IN HIP FRACTURE PREVALENCE - THE INFLUENCE OF HIP FRACTURE INCIDENCE AND SURVIVAL
Authors: MELTON LJ THERNEAU TM LARSON DR
Citation: Lj. Melton et al., LONG-TERM TRENDS IN HIP FRACTURE PREVALENCE - THE INFLUENCE OF HIP FRACTURE INCIDENCE AND SURVIVAL, Osteoporosis international, 8(1), 1998, pp. 68-74
LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS IN THE 90S -PATIENT SURVIVAL AND RESOURCE UTILIZATION
Authors: KIM WR WIESNER KH THERNEAU TM MALINCHOC M KROM RAF EVANS RW DICKSON ER CRIPPIN JS KLINTMALM GBG RAKELA J STARZL TE
Citation: Wr. Kim et al., LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS IN THE 90S -PATIENT SURVIVAL AND RESOURCE UTILIZATION, Hepatology, 28(4), 1998, pp. 907-907
INCREASED RISK OF CHRONIC LIVER-FAILURE IN ADULTS WITH HETEROZYGOUS ALPHA(1)-ANTITRYPSIN DEFICIENCY
Authors: GRAZIADEI IW JOSEPH JJ WIESNER RH THERNEAU TM BATTS KP PORAYKO MK
Citation: Iw. Graziadei et al., INCREASED RISK OF CHRONIC LIVER-FAILURE IN ADULTS WITH HETEROZYGOUS ALPHA(1)-ANTITRYPSIN DEFICIENCY, Hepatology, 28(4), 1998, pp. 1058-1063
OPTIMAL TIMING OF LIVER-TRANSPLANTATION FOR PRIMARY BILIARY-CIRRHOSIS
Authors: KIM WR WIESNER RH THERNEAU TM POTERUCHA JJ PORAYKO MK EVANS RW KLINTMALM GB CRIPPIN JS KROM RA DICKSON ER
Citation: Wr. Kim et al., OPTIMAL TIMING OF LIVER-TRANSPLANTATION FOR PRIMARY BILIARY-CIRRHOSIS, Hepatology, 28(1), 1998, pp. 33-38
BONE-DISEASE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS - PREVALENCE, SEVERITY AND PREDICTION OF PROGRESSION
Authors: ANGULO P THERNEAU TM JORGENSEN RA DESOTEL CK EGAN KS DICKSON ER HAY JE LINDOR KD
Citation: P. Angulo et al., BONE-DISEASE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS - PREVALENCE, SEVERITY AND PREDICTION OF PROGRESSION, Journal of hepatology, 29(5), 1998, pp. 729-735
LONG-TERM URSODEOXYCHOLIC ACID THERAPY DELAYS HISTOLOGIC PROGRESSION IN PRIMARY BILIARY-CIRRHOSIS
Authors: ANGULO P BATTS KP THERNEAU TM JORGENSEN RA DICKSON ER LINDOR KD
Citation: P. Angulo et al., LONG-TERM URSODEOXYCHOLIC ACID THERAPY DELAYS HISTOLOGIC PROGRESSION IN PRIMARY BILIARY-CIRRHOSIS, Gastroenterology, 114(4), 1998, pp. 21-21
THE TIME-COURSE OF HISTOLOGICAL PROGRESSION IN PRIMARY SCLEROSING CHOLANGITIS
Authors: ANGULO P THERNEAU TM LARSON DR BATTS KP LARUSSO NF LINDOR KD
Citation: P. Angulo et al., THE TIME-COURSE OF HISTOLOGICAL PROGRESSION IN PRIMARY SCLEROSING CHOLANGITIS, Gastroenterology, 114(4), 1998, pp. 23-23
THE MAYO RISK SCORE INCREASES RAPIDLY IN THE TERMINAL PHASE OF PRIMARY SCLEROSING CHOLANGITIS
Authors: KIM WR LINDOR KD POTERUCHA JJ BENSON JT THERNEAU TM DICKSON ER
Citation: Wr. Kim et al., THE MAYO RISK SCORE INCREASES RAPIDLY IN THE TERMINAL PHASE OF PRIMARY SCLEROSING CHOLANGITIS, Gastroenterology, 114(4), 1998, pp. 315-315
INCIDENCE OF CANCER IN PRIMARY BILIARY-CIRRHOSIS - THE MAYO EXPERIENCE
Authors: NIJHAWAN PK THERNEAU TM DICKSON ER LINDOR KD
Citation: Pk. Nijhawan et al., INCIDENCE OF CANCER IN PRIMARY BILIARY-CIRRHOSIS - THE MAYO EXPERIENCE, Gastroenterology, 114(4), 1998, pp. 464-464
WALDENSTROMS-MACROGLOBULINEMIA - A PROSPECTIVE-STUDY COMPARING DAILY ORAL VERSUS INTERMITTENT CHLORAMBUCIL
Authors: KYLE RA GREIPP PR GERTZ MA WITZIG TE LUST JA LACY MQ THERNEAU TM
Citation: Ra. Kyle et al., WALDENSTROMS-MACROGLOBULINEMIA - A PROSPECTIVE-STUDY COMPARING DAILY ORAL VERSUS INTERMITTENT CHLORAMBUCIL, British Journal of Haematology, 102(1), 1998, pp. 244-244
RELATIONSHIP BETWEEN DNA-PLOIDY AND FUNCTIONAL ESTROGEN-RECEPTORS IN OPERABLE PROSTATE-CANCER
Authors: NATIV O UMEHARA T COLVARD DS THERNEAU TM FARROW GM SPELSBERG TC LIEBER MM
Citation: O. Nativ et al., RELATIONSHIP BETWEEN DNA-PLOIDY AND FUNCTIONAL ESTROGEN-RECEPTORS IN OPERABLE PROSTATE-CANCER, European urology, 32(1), 1997, pp. 96-99
RHDNASE AS AN EXAMPLE OF RECURRENT EVENT ANALYSIS
Authors: THERNEAU TM HAMILTON SA
Citation: Tm. Therneau et Sa. Hamilton, RHDNASE AS AN EXAMPLE OF RECURRENT EVENT ANALYSIS, Statistics in medicine, 16(18), 1997, pp. 2029-2047
INCIDENCE OR CHOLANGIOCARCINOMA IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
Authors: PASHA TM PETZ J LUDWIG J THERNEAU TM BENSON JT MALINCHOC M DICKSON ER LINDOR KD
Citation: Tm. Pasha et al., INCIDENCE OR CHOLANGIOCARCINOMA IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS, Hepatology, 26(4), 1997, pp. 165-165
A REVISED NATURAL-HISTORY MODEL FOR PRIMARY SCLEROSING CHOLANGITIS OBVIATES THE NEED FOR LIVER HISTOLOGY
Authors: KIM WR THERNEAU TM WIESNER RH MALINCHOC M KAPLAN MM WILLIAMS R LINDOR KD DICKSON ER
Citation: Wr. Kim et al., A REVISED NATURAL-HISTORY MODEL FOR PRIMARY SCLEROSING CHOLANGITIS OBVIATES THE NEED FOR LIVER HISTOLOGY, Hepatology, 26(4), 1997, pp. 935-935
COMPARISON OF 3 DIFFERENT DOSES OF URSODEOXYCHOLIC ACID IN THE TREATMENT OF PRIMARY BILIARY-CIRRHOSIS - A RANDOMIZED TRIAL
Authors: LINDOR KD JORGENSEN R THERNEAU TM SMITH C MAHONEY DW DICKSON ER
Citation: Kd. Lindor et al., COMPARISON OF 3 DIFFERENT DOSES OF URSODEOXYCHOLIC ACID IN THE TREATMENT OF PRIMARY BILIARY-CIRRHOSIS - A RANDOMIZED TRIAL, Hepatology, 26(4), 1997, pp. 1240-1240
A COMPARISON OF HUMAN-LEUKOCYTE ANTIGEN ALLELES IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA WITH AND WITHOUT CHRONIC VIRAL-HEPATITIS
Authors: BRANDHAGEN DJ GROSS JB POTERUCHA JJ ABDELMALEK MF GUERRERO RB THERNEAU TM PERSING DH
Citation: Dj. Brandhagen et al., A COMPARISON OF HUMAN-LEUKOCYTE ANTIGEN ALLELES IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA WITH AND WITHOUT CHRONIC VIRAL-HEPATITIS, Hepatology, 26(4), 1997, pp. 1427-1427
HUMAN-LEUKOCYTE ANTIGEN DR ALLELES AND RISK OF TRANSPLANTATION IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: BRANDHAGEN DJ GROSS JB POTERUCHA JJ ABDELMALEK MF SMITH CI RIBEIRO AC CZAJA AJ BATTS KP GOSSARD AA THERNEAU TM WIESNER RH PERSING DH
Citation: Dj. Brandhagen et al., HUMAN-LEUKOCYTE ANTIGEN DR ALLELES AND RISK OF TRANSPLANTATION IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 26(4), 1997, pp. 1428-1428
A PROGNOSTIC MODEL FOR THE OUTCOME OF LIVER-TRANSPLANTATION IN PATIENTS WITH CHOLESTATIC LIVER-DISEASE
Authors: RICCI P THERNEAU TM MALINCHOC M BENSON JT PETZ JL KLINTMALM GB CRIPPIN JS WIESNER RH STEERS JL RAKELA J STARZL TE DICKSON ER
Citation: P. Ricci et al., A PROGNOSTIC MODEL FOR THE OUTCOME OF LIVER-TRANSPLANTATION IN PATIENTS WITH CHOLESTATIC LIVER-DISEASE, Hepatology, 25(3), 1997, pp. 672-677
QUANTITATIVE MEASUREMENT OF AUTOANTIBODIES TO RECOMBINANT MITOCHONDRIAL ANTIGENS IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS, RELATIONSHIP OF LEVELS OF AUTOANTIBODIES TO DISEASE PROGRESSION
Authors: VANNORSTRAND MD MALINCHOC M LINDOR KD THERNEAU TM GERSHWIN ME LEUNG PSC DICKSON ER HOMBURGER HA
Citation: Md. Vannorstrand et al., QUANTITATIVE MEASUREMENT OF AUTOANTIBODIES TO RECOMBINANT MITOCHONDRIAL ANTIGENS IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS, RELATIONSHIP OF LEVELS OF AUTOANTIBODIES TO DISEASE PROGRESSION, Hepatology, 25(1), 1997, pp. 6-11
PRIMARY BILIARY-CIRRHOSIS - DUTCH APPLICATION OF THE MAYO MODEL BEFORE AND AFTER ORTHOTOPIC LIVER-TRANSPLANTATION
Authors: VANDAM GM VERBAAN BW THERNEAU TM DICKSON ER MALINCHOC M MURTAUGH PA HUIZENGA JR GIPS CH
Citation: Gm. Vandam et al., PRIMARY BILIARY-CIRRHOSIS - DUTCH APPLICATION OF THE MAYO MODEL BEFORE AND AFTER ORTHOTOPIC LIVER-TRANSPLANTATION, Hepato-gastroenterology, 44(15), 1997, pp. 732-743
A TRIAL OF 3 REGIMENS FOR PRIMARY AMYLOIDOSIS - COLCHICINE ALONE, MELPHALAN AND PREDNISONE, AND MELPHALAN, PREDNISONE, AND COLCHICINE
Authors: KYLE RA GERTZ MA GREIPP PR WITZIG TE LUST JA LACY MQ THERNEAU TM
Citation: Ra. Kyle et al., A TRIAL OF 3 REGIMENS FOR PRIMARY AMYLOIDOSIS - COLCHICINE ALONE, MELPHALAN AND PREDNISONE, AND MELPHALAN, PREDNISONE, AND COLCHICINE, The New England journal of medicine, 336(17), 1997, pp. 1202-1207
URSODEOXYCHOLIC ACID DELAYS THE ONSET OF ESOPHAGEAL-VARICES IN PRIMARY BILIARY-CIRRHOSIS
Authors: LINDOR KD JORGENSEN RA THERNEAU TM MALINCHOC M DICKSON ER
Citation: Kd. Lindor et al., URSODEOXYCHOLIC ACID DELAYS THE ONSET OF ESOPHAGEAL-VARICES IN PRIMARY BILIARY-CIRRHOSIS, Mayo Clinic proceedings, 72(12), 1997, pp. 1137-1140
LONG-TERM SURVIVAL (10+ YEARS) IN 30 PATIENTS WITH PRIMARY AMYLOIDOSIS (AL)
Authors: KYLE RA GERTZ MA GREIPP PR WITZIG TE LUST JA LACY MQ THERNEAU TM
Citation: Ra. Kyle et al., LONG-TERM SURVIVAL (10+ YEARS) IN 30 PATIENTS WITH PRIMARY AMYLOIDOSIS (AL), Blood, 90(10), 1997, pp. 375-375
CYTOGENETIC ABNORMALITIES IN MULTIPLE-MYELOMA AND RELATED PLASMA-CELLDISORDERS - A COMPARISON OF CONVENTIONAL CYTOGENETIC ANALYSIS TO FLUORESCENT IN-SITU HYBRIDIZATION WITH SIMULTANEOUS CYTOPLASMIC IMMUNOGLOBULIN STAINING
Authors: FONSECA R AHMANN GJ JUNEAU AL JALAL SM DEWALD GW LARSON DR THERNEAU TM GREIPP PR
Citation: R. Fonseca et al., CYTOGENETIC ABNORMALITIES IN MULTIPLE-MYELOMA AND RELATED PLASMA-CELLDISORDERS - A COMPARISON OF CONVENTIONAL CYTOGENETIC ANALYSIS TO FLUORESCENT IN-SITU HYBRIDIZATION WITH SIMULTANEOUS CYTOPLASMIC IMMUNOGLOBULIN STAINING, Blood, 90(10), 1997, pp. 1558-1558
CYTOGENETIC ABNORMALITIES IN SYSTEMIC AMYLOIDOSIS - A COMPARISON OF CONVENTIONAL CYTOGENETIC ANALYSIS TO FLUORESCENT IN-SITU HYBRIDIZATION WITH SIMULTANEOUS CYTOPLASMIC IMMUNOGLOBULIN STAINING
Authors: FONSECA R AHMANN GJ JUNEAU AL JALAL SM DEWALD GW LARSON DR THERNEAU TM GERTZ MA GREIPP PR
Citation: R. Fonseca et al., CYTOGENETIC ABNORMALITIES IN SYSTEMIC AMYLOIDOSIS - A COMPARISON OF CONVENTIONAL CYTOGENETIC ANALYSIS TO FLUORESCENT IN-SITU HYBRIDIZATION WITH SIMULTANEOUS CYTOPLASMIC IMMUNOGLOBULIN STAINING, Blood, 90(10), 1997, pp. 1559-1559
Risultati: 1-25 | 26-50 | 51-53